BioReperia
Pascal Winnen is the CEO and co-founder of HEMEX AG, an organization dedicated to supporting European start-ups in the healthcare sector by facilitating the development and market introduction of innovative pharmaceuticals, medical devices, and diagnostics. With a robust portfolio of roles, Pascal also serves on various boards, including Aspivix and BioReperia, and holds positions such as Board Observer at Sleepiz AG and CEO of M4IVD and Hemex LLC. Pascal's extensive expertise in clinical research and telecommunication engineering, bolstered by a Master of Science degree from Universität für Weiterbildung Krems, underpins a commitment to advancing medical technologies and solutions in various capacities across the healthcare landscape.
This person is not in any teams
This person is not in any offices
BioReperia
1 followers
BioReperia is located at Linköpings University. Their researchers have more than 10 years experience developing and using zebrafish models for medical research including toxicology and tumor biology. Their models are today widely used in both academic and industrial research and drug development projects around the globe.